Hes1 Increases the Invasion Ability of Colorectal Cancer Cells via the STAT3-MMP14 Pathway

M T Weng1,2,3, P N Tsao4, H L Lin3

  • 1Department of Internal Medicine, Far-Eastern Memorial Hospital, New Taipei, Taiwan.

Plos One
|December 10, 2015
PubMed

Insights

Hairy/enhancer of split 1 (Hes1) promotes colorectal cancer (CRC) invasion via the STAT3-MMP14 pathway. High Hes1 expression predicts poor prognosis in CRC patients, suggesting Hes1 as a therapeutic target.

Area of Science:

  • Oncology
  • Molecular Biology
  • Cell Biology

Background:

  • The Notch pathway is implicated in tumor-initiating cell self-renewal and colorectal cancer (CRC) development.
  • Hairy/enhancer of split (HES) proteins, key Notch targets, are involved in various cancers.
  • Deregulated Notch1 and Jagged1 expression is noted in CRC.

Purpose of the Study:

  • To investigate the role of Hes1 in colorectal cancer tumorigenesis.
  • To elucidate the molecular mechanisms by which Hes1 influences CRC progression.
  • To evaluate Hes1 as a prognostic biomarker in CRC.

Main Methods:

  • Functional assays involving Hes1 knockdown and overexpression in CRC cells.
  • Analysis of STAT3 phosphorylation and MMP14 protein levels.
  • Correlation analysis of Hes1 mRNA expression with patient prognosis.

Main Results:

  • Hes1 knockdown induced CRC cell senescence and reduced invasion.
  • Hes1 overexpression increased STAT3 phosphorylation and MMP14 levels.
  • High Hes1 mRNA expression in human CRC correlated with poor prognosis.

Conclusions:

  • Hes1 promotes CRC cell invasion through the STAT3-MMP14 pathway.
  • Hes1 expression level is a significant predictor of poor prognosis in colorectal cancer patients.
  • Targeting Hes1 may offer a therapeutic strategy for CRC.

Related Concept Videos

Role Of Notch Signalling In Intestinal Stem Cell Renewal01:12

Role Of Notch Signalling In Intestinal Stem Cell Renewal

Notch signaling was first discovered in Drosophila melanogaster, where it is involved in cell lineage differentiation. Notch signaling regulates the maintenance and differentiation of intestinal stem cells or ISCs by controlling the expression of atonal homolog 1 or Atoh1. Atoh1 directs cells to differentiate into secretory cells.
Direct cell-to-cell contact is needed for the activation of Notch signaling. The signal is initiated when a notch ligand binds to a receptor on an adjacent cell, also...
2.6K
Metastasis02:30

Metastasis

Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
6.8K
Cancer Cell Migration through Invadopodia01:35

Cancer Cell Migration through Invadopodia

Invadosome is a broad category of cell surface structures with proteolytic activity that  degrades the extracellular matrix (ECM). Invadosomes are present in normal cell types, including macrophages, endothelial cells, and neurons, as well as tumor cells. Although the macrophage podosomes and tumor cell invadopodia are classified as invadosomes, they have different structures, molecular pathways, and functions. Podosomes are short structures that last for a few minutes. However,...
3.5K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
5.1K